Publications

18

Feb, 2002

TREC Response to Antiretroviral Therapy in HIV-infected Children in the PENTA 5 Trial

 

Authors: De Rossi A, Klein N, Walker AS, De Forni D, Babiker A, King D, Gibb DM for the PENTA Group.

Published in: 9th Conference on Retroviruses and Opportunistic Infections February 24-28, 2002 – Seattle. Poster 807-W.

Read

18

Feb, 2002

The Impact of HIV-1 Subtypes on Virological Response and Emergence of Resistance in the PENTA 5 Trial

 

Authors: Pillay D, Gibb DM, Walker AS, De Rossi A, Kaye S, Ait-Khaled M, Muñoz-Fernandez M, Babiker A for the PENTA Group.

Published in: Conference on Retroviruses and Opportunistic Infections February 24-28, 2002 – Seattle. Poster 813-W

Read

18

Apr, 2001

Pharmacokinetics (PK) of Nelfinavir (NFV) and its Active Metabolite (M8) in Very Young Infants Infected with Human Immunodeficiency Virus (HIV)

 

Authors: Litalien C, Faye A, Compagnucci A, Jacqz-Aigrain E.

Published in: Pediatric Academic Societies 2001 Annual Meeting, April 28 – May 1 2001, Baltimore MD. Abstract 2609.

18

Apr, 2001

T-cell re-population in HIV-infected children on highly active anti-retroviral therapy (HAART)

 

Authors: King DJ, Gotch FM, Larsson-Sciard EL; Paediatric European Network for Treatment of AIDS (PENTA)

Published in: Clin Exp Immunol. 2001 Sep;125(3):447-54.

Read

18

Apr, 2001

Evolution of drug resistance in antiretroviral therapy-naïve children in PENTA 5.

 

Authors: Loveday. C., Walker. A.S., Gibb. D.M., on behalf of the PENTA virology Group

Published in:  Fifth International Workshop on HIV Drug Resistance and Treatment Strategies, 2001, Scottsdale, USA (abstract 109), Antiviral Therapy 2001, Vol 6 (supplement 1) : 82

18

Apr, 2001

T cell repopulation in HIV infected children on highly active anti-retroviral therapy (HAART).

 

Authors: King D J.S., Gotch F M., Larsson-Sciard E.

Published in: Clinical and Experimental Immunology 2001, vol 125, no. 3 pp. 447-454.

18

Feb, 2001

Evaluation of Toxicity, Tolerability and Antiviral Activity of Early d4T+ddI+Nelfinavir (NFV) Therapy in HIV-1 Vertically Infected Infants : 24 Week Preliminary Results from the PENTA 7 Study.

 

Authors: Faye A , Compagnucci A., Saidi Y. for the PENTA 7 Executive Committee

Published in: 8th Conference on Retroviruses and Opportunistic Infections, Chicago 4-8 February 2001 Poster 678

Read

18

Jul, 2000

Nelfinavir doses should be increased in infants less than 3 months.

 

Authors: Litalien C. Giaquinto C. Faye A. Mechinaud F. Grosch I. Compagnucci A. Jacqz-Aigrain E.

Published in: XIII International AIDS Conference, Durban, South Africa, 9-14 July 2000. Abstract Mo PEB 2213

Read

19

Apr, 2000

Current evidence for the use of pediatric antiretroviral therapy – a PENTA analysis

 

Authors: Sharland M, Gibb DM, Giaquinto C.

Published in: European Journal of Pediatrics 2000; 159:649-656.

Read

19

Apr, 2000

Variable use of therpaeutic interventions for children with human immunodeficiency virus type 1 infection in Europe.

 

Authors: Bernardi S, Thorne C, Newell ML, Giaquinto C,Tovo PA, Rossi P.

Published in: European Journal of Pediatrics 2000; 159(3):170-5

Read